Clin2
NCT07708441Possibly a fitNot yet recruiting

Study of an experimental drug for hard-to-treat high blood pressure

Uncontrolled or Resistant Hypertension

Part of Heart & circulation clinical trials.

This study tests an investigational drug called HRS-1780 for people with high blood pressure that is not well controlled or is resistant to treatment. The purpose is to see if it can lower blood pressure more effectively than current options.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
914 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You must be between 18 and 80 years old.
  • Your blood pressure (top number) should be between 140 and 170 mmHg when measured seated, and it must be poorly controlled despite treatment, or you have resistant hypertension.
  • You must not have certain other causes of high blood pressure (like kidney artery narrowing, thyroid problems, or Cushing's syndrome).
  • You must not have had serious heart problems (like heart attack, stroke, or heart failure hospitalization) in the last 6 months.
  • You must not be taking certain blood pressure medications called MRAs or potassium-sparing diuretics (e.g., spironolactone) within the past 4 weeks.
  • You must have normal potassium levels, and acceptable kidney and liver function tests.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07528027Recruiting· Phase 3
Study of a new drug for high blood pressure with overweight or obesity

This study tests a new medication called HRS-7535 for people who have high blood pressure and are also overweight or obese. The drug may help lower blood pressure and support weight loss, and this trial will compare it to a placebo to see if it works well and is safe.

Beijing, Beijing Municipality
NCT07142356Recruiting· Phase 2
New oral medication for high blood pressure not controlled by current pills

This study tests a new medication, RTN-001, for people whose blood pressure remains high even when taking multiple blood pressure medications. The goal is to see if this drug can lower blood pressure more effectively.

Alexander City, Alabama
NCT07660796Not yet recruiting· Phase 3
Blood pressure medication study for high blood pressure

This study tests a new blood pressure medication to see if it is safe and effective for people with high blood pressure. It may help lower your blood pressure and reduce health risks.

Goyang-si, Gyeonggi-do
NCT07758634Recruiting· Phase 1/Phase 2
Study of an experimental treatment for high blood pressure

This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.

Port Orange, Florida
NCT07551167Recruiting· Phase 1
Safety Study of HRS-5765 in Healthy Adults

This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.

Beijing, Beijing Municipality

Hear when a new Uncontrolled or Resistant Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.